Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (232)	11/12/1998 11:56:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1073

>> Biotechs have had quite a run-up these since the beginning of September, and I'm a little concerned that the combination of a little froth (e.g., OXGN) and the GERN and ENMD debacles will hurt the whole sector for a while. << I get so ticked when this happens. Some guy in the GERN thread, last week, was telling me that I was insane when I suggested that an "EntreMed" was bad for the sector. He, of course, couldn't spell anything other than "momentum", and the temptation to invest in jeans was just too overwhelming for him to resist. With respect to ARIA, I hope we can M&A Berger's butt into radical change......... exchange2000.com